Peter Löser

2.1k total citations
33 papers, 1.6k citations indexed

About

Peter Löser is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Peter Löser has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Genetics and 6 papers in Physiology. Recurrent topics in Peter Löser's work include Virus-based gene therapy research (14 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (12 papers). Peter Löser is often cited by papers focused on Virus-based gene therapy research (14 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (12 papers). Peter Löser collaborates with scholars based in Germany, Australia and United States. Peter Löser's co-authors include Mike Strauss, Volker Sandig, Gary Jennings, Anna M. Wobus, Claus Scheidereit, Anke Guhr, Armin Kurtz, M. Hinz, Stephan Mathas and Daniel Krappmann and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Peter Löser

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Löser Germany 20 1.1k 551 247 235 217 33 1.6k
Vivian W.Y. Wong United States 8 995 0.9× 171 0.3× 435 1.8× 189 0.8× 219 1.0× 9 1.6k
Jiexing Cai United States 9 1.6k 1.5× 177 0.3× 347 1.4× 198 0.8× 201 0.9× 9 2.4k
Ole Kristoffer Olstad Norway 24 1.1k 1.0× 214 0.4× 264 1.1× 274 1.2× 362 1.7× 103 1.9k
Yvonne Myal Canada 24 610 0.6× 171 0.3× 486 2.0× 152 0.6× 299 1.4× 55 1.5k
Amitava Mukherjee United States 17 1.0k 0.9× 190 0.3× 260 1.1× 329 1.4× 182 0.8× 34 2.0k
Olaf R.F. Mook Netherlands 18 919 0.8× 229 0.4× 361 1.5× 122 0.5× 498 2.3× 26 1.6k
Gediminas Greicius Singapore 19 1.1k 1.0× 297 0.5× 546 2.2× 238 1.0× 136 0.6× 25 1.7k
Aimee Landry United States 10 609 0.6× 322 0.6× 149 0.6× 346 1.5× 170 0.8× 11 1.3k
Shelley Force Aldred United States 12 824 0.8× 205 0.4× 182 0.7× 144 0.6× 322 1.5× 24 1.4k

Countries citing papers authored by Peter Löser

Since Specialization
Citations

This map shows the geographic impact of Peter Löser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Löser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Löser more than expected).

Fields of papers citing papers by Peter Löser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Löser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Löser. The network helps show where Peter Löser may publish in the future.

Co-authorship network of co-authors of Peter Löser

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Löser. A scholar is included among the top collaborators of Peter Löser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Löser. Peter Löser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wells, Christine A., Anke Guhr, Amos Bairoch, et al.. (2024). Guidelines for managing and using the digital phenotypes of pluripotent stem cell lines. Stem Cell Reports. 19(10). 1369–1378. 3 indexed citations
2.
3.
Guhr, Anke, et al.. (2015). Human Embryonic and Induced Pluripotent Stem Cell Research Trends: Complementation and Diversification of the Field. Stem Cell Reports. 4(5). 914–925. 20 indexed citations
4.
Schuldt, Bernhard, Anke Guhr, Michael Lenz, et al.. (2013). Power-Laws and the Use of Pluripotent Stem Cell Lines. PLoS ONE. 8(1). e52068–e52068. 5 indexed citations
5.
Löser, Peter, et al.. (2012). Scope and Impact of International Research in Human Pluripotent Stem Cells. Stem Cell Reviews and Reports. 8(4). 1048–1055. 7 indexed citations
6.
Müller, Frank, Johanna Goldmann, Peter Löser, & Jeanne F. Loring. (2010). A Call to Standardize Teratoma Assays Used to Define Human Pluripotent Cell Lines. Cell stem cell. 6(5). 412–414. 104 indexed citations
7.
Wobus, Anna M. & Peter Löser. (2008). Humane embryonale Stammzellen im Kontext internationaler Forschungsaktivitäten. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 51(9). 994–1004.
8.
Wüest, Thomas, Gerald W. Both, Alfred M. Prince, Christian Hofmann, & Peter Löser. (2004). Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice. Vaccine. 22(21-22). 2717–2721. 29 indexed citations
9.
Hofmann, Christian, et al.. (2004). Identification of an ovine atadenovirus gene whose product activates the viral E2 promoter: possible involvement of E2F-1. Virology. 318(1). 79–89. 4 indexed citations
10.
Cichon, G, Thomas E. Willnow, Susanne Herwig, et al.. (2004). Non‐physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage. The Journal of Gene Medicine. 6(2). 166–175. 27 indexed citations
11.
Catley, Matthew C., Joanna E. Chivers, Lisa Cambridge, et al.. (2003). IL‐1β‐dependent activation of NF‐κB mediates PGE2 release via the expression of cyclooxygenase‐2 and microsomal prostaglandin E synthase. FEBS Letters. 547(1-3). 75–79. 87 indexed citations
12.
Löser, Peter, et al.. (2003). Preparation of Ovine Adenovirus Vectors. Humana Press eBooks. 69. 415–426. 6 indexed citations
13.
Löser, Peter, et al.. (2002). Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery. Current Gene Therapy. 2(2). 161–171. 34 indexed citations
14.
Bergmann, Martin, Peter Löser, Rainer Dietz, & Rüdiger von Harsdorf. (2001). Effect of NF- κ B Inhibition on TNF- α -induced Apoptosis and Downstream Pathways in Cardiomyocytes. Journal of Molecular and Cellular Cardiology. 33(6). 1223–1232. 60 indexed citations
15.
Schnieders, Frank, et al.. (2001). System for Efficient Helper-Dependent Minimal Adenovirus Construction and Rescue. Human Gene Therapy. 12(6). 643–657. 17 indexed citations
16.
Löser, Peter, et al.. (2000). Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle. Gene Therapy. 7(17). 1491–1498. 23 indexed citations
17.
Cichon, Günter, Hartmut Schmidt, Tahar Benhidjeb, et al.. (1999). Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. The Journal of Gene Medicine. 1(5). 360–371. 83 indexed citations
18.
Brand, Karsten, et al.. (1998). Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach. Gene Therapy. 5(10). 1363–1371. 53 indexed citations
19.
Löser, Peter, Volker Sandig, И. В. Кириллова, & Mike Strauss. (1996). Evaluation of HBV Promoters for Use in Hepatic Gene Therapy. Biological Chemistry Hoppe-Seyler. 377(3). 187–194. 14 indexed citations
20.
Sandig, Volker, Peter Löser, André Lieber, Mark A. Kay, & Mike Strauss. (1996). HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.. PubMed. 3(11). 1002–9. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivian W.Y. Wong Breakdown of academic impact, for papers by Jiexing Cai Breakdown of academic impact, for papers by Ole Kristoffer Olstad Breakdown of academic impact, for papers by Yvonne Myal Breakdown of academic impact, for papers by Amitava Mukherjee Breakdown of academic impact, for papers by Olaf R.F. Mook Breakdown of academic impact, for papers by Gediminas Greicius Breakdown of academic impact, for papers by Aimee Landry Breakdown of academic impact, for papers by Shelley Force Aldred
Rankless by CCL
2026